BIOMED任命新的商务主管
2009年9月8日,BIOMED任命新的商务主管Bev Acreman,她曾任职于Taylor & Francis,并为其发展成为重要的STM出版商做出了巨大的贡献。
Top-level appointment at the world’s largest open access publisher
Today, BioMed Central, the world’s largest open access publisher, announces that Bev Acreman is to join the company as Commercial Director.
Bev comes to BioMed Central from Taylor & Francis, where she has played a significant role in growing the company to its present position as a major player in STM publishing. With the proven success of the open access publishing model, BioMed Central is experiencing rapid growth in manuscript submissions, has many exciting new products in development and sees many opportunities for exciting partnerships and relationships with academic institutions, libraries and societies. In her new role, Bev will use her wide experience of STM publishing to ensure that BioMed Central continues to lead the way in delivering excellent service to authors, readers and institutional customers.
Bev’s extensive previous involvement with learned society journal publishing will be a major asset as BioMed Central continues to develop its own rapidly expanding society publishing programme.
Speaking of her appointment Beverley Acreman said "I’m tremendously excited to be joining BioMed Central and am passionate about driving the business forward. I am looking forward to working with authors, institutions and societies alike to help them realise the huge potential of open access".
Media Contact
Matt McKay
Head of Public Relations
BioMed Central
Tel: +44 (0) 203 1922 216
Mob: +44 (0) 7825 257 423
Email: matthew.mckay@biomedcentral.com
Notes to Editors
BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
原文出处: http://www.biomedcentral.com/info/presscenter/pressreleases?pr=20090908
